These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Stereotactic radiotherapy to oligoprogressive lesions detected with Onal C; Ozyigit G; Oymak E; Guler OC; Tilki B; Hurmuz P; Akyol F Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3683-3692. PubMed ID: 33693965 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience. Ozyigit G; Hurmuz P; Akinci D; Esen SCB; Yilmaz MT; Akdogan B; Akyol FH Cancer Radiother; 2020 Dec; 24(8):805-811. PubMed ID: 32565071 [TBL] [Abstract][Full Text] [Related]
32. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
33. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Kwon DH; Shakhnazaryan N; Shui D; Hong JC; Mohamad O; de Kouchkovsky I; Borno HT; Bose R; Chou J; Desai A; Fong L; Friedlander TW; Koshkin VS; Aggarwal RR; Feng FY; Hope TA; Small EJ Urol Oncol; 2023 Mar; 41(3):145.e7-145.e15. PubMed ID: 36435709 [TBL] [Abstract][Full Text] [Related]
34. Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation. Kroeze SGC; Henkenberens C; Schmidt-Hegemann NS; Vogel MME; Kirste S; Becker J; Burger IA; Derlin T; Bartenstein P; Eiber M; Mix M; la Fougère C; Christiansen H; Belka C; Combs SE; Grosu AL; Müller AC; Guckenberger M Eur Urol Focus; 2021 Mar; 7(2):309-316. PubMed ID: 31495759 [TBL] [Abstract][Full Text] [Related]
35. Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques. Rowe LS; Harmon S; Horn A; Shankavaram U; Roy S; Ning H; Lindenberg L; Mena E; Citrin DE; Choyke P; Turkbey B Radiat Oncol; 2021 Feb; 16(1):32. PubMed ID: 33568190 [TBL] [Abstract][Full Text] [Related]
36. Re-defining Tissot S; Wynn J; Tran V; Farag M; Wong LM; Ng M BJU Int; 2023 Oct; 132(4):411-419. PubMed ID: 37216190 [TBL] [Abstract][Full Text] [Related]
37. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. Bouman-Wammes EW; van Dodewaard-De Jong JM; Dahele M; Cysouw MCF; Hoekstra OS; van Moorselaar RJA; Piet MAH; Verberne HJ; Bins AD; Verheul HMW; Slotman BJ; Oprea-Lager DE; Van den Eertwegh AJM Clin Genitourin Cancer; 2017 Oct; 15(5):e773-e782. PubMed ID: 28462855 [TBL] [Abstract][Full Text] [Related]